Global Next-generation Sequencing Trends
An End-user Perspective
22-Sep-2014
North America
Customer Research
The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-related research is the dominant use for NGS technologies. The popularity of RNA-Seq continues to surge, with half of the respondents planning to use this application in the next 24 months. The most significant bottleneck in the NGS workflow is the length of time spent analyzing data. The in-house annual budget for NGS data interpretation software is more than double that of those who outsource.
Research Background and Objectives
Methods
Sample Details
Executive Summary
Executive Summary (continued)
Outsourced Compared to In-house NGS—Current and Planned
Importance of Attributes in Purchasing Sequencing Instruments
Primary Research Area of NGS
Average Time Spent on Analyzing and Interpreting NGS Data
Annual Budget for Software for Analyzing and Interpreting NGS Data
Technologies Used In-house—Current and Planned
Outsourced Technologies—Current and Planned
Average Number of Currently Installed/Shared NGS Instruments
Average Number of Currently Installed/Shared Capillary Electrophoresis Sequencing Instruments
Importance of Attributes in Purchasing Sequencing Instruments
Top 10 Sequencing Instruments—Installation Details by Brands
Sequencing Instruments—Installation Details by Brands
Purchase Potential of New Upcoming Sequencing Technologies
Outsourcers of NGS—Current and Planned
Top Outsourced Commercial Service Providers—Current and Planned
Primary Research Area of NGS
Sequencing Applications—Current and Future
NGS Reagents Providers
Overall Experience atings of the Most sed roviders
Expected Sample Throughput for NGS Projects in 2014
Average Time Spent on Analyzing and Interpreting NGS Data
Average Number of Hours Spent on Analyzing and Interpreting NGS Data (continued)
Annual Budget for Software for Analyzing and Interpreting NGS Data
Per-sample Cost for NGS Interpretation
Top Companies Used for NGS Bioinformatics Purposes
Top Voted Providers of NGS Services
Sequencing Data Stored in the Cloud
Involvement in the Use of NGS Technologies
Location of the Laboratory
Location of the Organization
Current Positon
Legal Disclaimer
Technologies Currently Used In-house by Lab Location
Technologies Currently Used In-house by NGS Use
Technologies Planned to be Used In-house by Lab Location
Technologies Planned to be Used In-house by NGS Use
Technologies Currently Outsourced by Lab Location
Technologies Currently Outsourced by NGS Use
Technologies Planned to be Outsourced by Lab Location
Technologies Planned to be Outsourced by NGS Use
Importance of Attributes in Purchasing Sequencing Instruments by Lab Location
Importance of Attributes in Purchasing Sequencing Instruments by Lab Location (continued)
Imporance of Attributes in Purchasing Sequencing Instruments by NGS Use
Imporance of Attributes in Purchasing Sequencing Instruments by NGS Use (continued)
Sequencing Instruments—Currently Installed/Shared by Lab Location
Sequencing Instruments—Currently Installed/Shared by NGS Use
Sequencing Instruments—Planned to be Installed/Shared by Lab Location
Sequencing Instruments—Planned to be Installed/Shared by NGS Use
Sequencing Instruments—No Plans to Use by Lab Location
Sequencing Instruments—No Plans to Use by NGS Use
Purchase Potential of New Upcoming Sequencing Technologies by Lab Location
Purchase Potential of New Upcoming Sequencing Technologies by NGS Use
Currently Used Outsourcers of NGS by Lab Location
Currently Used Outsourcers of NGS by NGS Use
NGS Outsourcers Planned to be Used by Lab Location
NGS Outsourcers Planned to be Used by NGS Use
Currently Outsourced Commercial Service Providers
Currently Outsourced Commercial Service Providers (continued)
Commercial Service Providers Planned to be Outsourced
Commercial Service Providers Planned to be Outsourced (continued)
Primary Research Area of NGS by Lab Location
Primary Research Area of NGS by Lab Location (continued)
Primary Research Area of NGS by NGS Use
Primary Research Area of NGS by NGS Use (continued)
Currently Conducted Sequencing Applications by Lab Location
Currently Conducted Sequencing Applications by Lab Location (continued)
Currently Conducted Sequencing Applications by NGS Use
Currently Conducted Sequencing Applications by NGS Use (continued)
Sequencing Applications Planned to be Conducted by Lab Location
Sequencing Applications Planned to be Conducted by Lab Location (continued)
Sequencing Applications Planned to be Conducted by NGS Use
Sequencing Applications Planned to be Conducted by NGS Use (continued)
NGS Reagents Providers by Lab Location
NGS Reagents Providers by Lab Location (continued)
NGS Reagents Providers by NGS Use
NGS Reagents Providers by NGS Use (continued)
Average Time Spent on Analyzing and Interpreting NGS Data by Lab Location
Average Time Spent on Analyzing and Interpreting NGS Data by NGS Use
Companies Used for NGS Bioinformatics Purposes
Companies Used for NGS Bioinformatics Purposes (continued)
Best Providers of NGS Bioinformatics Services
Best Providers of NGS Bioinformatics Services (continued)
Involvement in the Use NGS Technologies by Lab Location
Involvement in the Use NGS Technologies by NGS Use
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Deliverable Type | Customer Research |
---|---|
No Index | Yes |
Podcast | No |
Author | Christi Bird |
WIP Number | NDE8-01-00-00-00 |
Is Prebook | No |